局部枸橼酸抗凝在间歇性血液透析中的应用进展  

Advances in the application of regional citrate anticoagulation in intermittent hemodialysis

作　　者：唐小琰 张凌[1] 付平[1] TANG Xiao-yan;ZHANG Ling;FU Ping(Department of Nephrology,West China Hospital,Sichuan University,Chengdu 610041,China;Department of Nephrology,Jianyang People's Hospital,Chengdu 641400,China)

机构地区：[1]四川大学华西医院肾脏内科,成都610041 [2]简阳市人民医院肾脏内科,简阳641400

出　　处：《中国血液净化》2021年第6期387-390,共4页Chinese Journal of Blood Purification

基　　金：四川大学华西医院临床研究孵化项目(2018HXFH018);四川大学华西医院学科卓越发展1.3.5工程项目(ZYGD18027)。

摘　　要：近年来,局部枸橼酸抗凝(regional citrate anticoagulation,RCA)在间歇性血液透析(intermittent hemodialysis,IHD)中使用逐步增多,对于存在出血高危风险及活动性出血的患者有其独特优势,本文回顾分析近年来国内外RCA在IHD中的应用,为其推广提供参考。In recent years,regional citrate anticoagulation(RCA)has been used increasingly in intermittent hemodialysis due to its unique advantages for patients with high risk of bleeding or active bleeding.In this paper,we review and analyze the application of RCA in intermittent hemodialysis in China and foreign countries in recent years,so as to provide a reference for its popularization.

关 键 词：局部抗凝 枸橼酸钠 血液透析 

分 类 号：R459.5[医药卫生—治疗学]